Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Radient Pharmaceuticals Announces Onko-Sure In Vitro Diagnostic Cancer Test Sales for Q1 2010 on Track
PR Canada
Saturday, February 6, 2010 - 1:02pm
tags:
Radient Pharmaceuticals, Onko-Sure
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Medical News Today
Saturday, February 6, 2010 - 12:52pm
tags:
Qiagen, Pfizer, glioblastoma multiforme
FDA OKs Javelin Pharmaceuticals' Dyloject NDA for Formal Review
Trading Markets
Saturday, February 6, 2010 - 12:41pm
tags:
Javelin, Dyloject, painkillers
Lannett to Submit NDA for Morphine Sulfate Products
Trading Markets
Saturday, February 6, 2010 - 12:39pm
tags:
Lannett, NDA, morphine sulfate
AG questions drug firms' use of free samples
Bennington Banner, VT
Saturday, February 6, 2010 - 12:37pm
tags:
samples
Pfizer still bidding for Ratiopharm
Trading Markets
Saturday, February 6, 2010 - 12:33pm
tags:
Pfizer, Ratiopharm
How Generic Medications Can Put Patients At Risk?
WBZ
Saturday, February 6, 2010 - 12:29pm
tags:
generics
Carping Over PARPs: Buyout Equals 'Negative' for BioMarin?
Bioworld
Saturday, February 6, 2010 - 12:24pm
tags:
Biomarin, PARP inhibitors
Keryx Biopharmaceuticals (NASDAQ: KERX) Responds to Erroneous Report About Planned Phase III Study for Patients With Colorectal Cancer
Yahoo/MarketWire
Saturday, February 6, 2010 - 12:22pm
tags:
Keryx, perifosine, colorectal cancer
Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
NY Times
Saturday, February 6, 2010 - 12:19pm
tags:
healthcare reform
FDA Decision Due on Wider Use of Crestor
Forbes
Saturday, February 6, 2010 - 12:10pm
tags:
Crestor, c-reactive protein, AstraZeneca
FDA Clears Drug Chief of Conflict
Wall St Journal
Saturday, February 6, 2010 - 12:08pm
tags:
FDA
Drug stocks fall; Alkermes rallies on upgrade
MarketWatch
Saturday, February 6, 2010 - 12:06pm
tags:
Alkermes
Inhibitex Regains Compliance with NASDAQ Listing Requirements
Yahoo/BusinessWire
Saturday, February 6, 2010 - 12:05pm
tags:
Inhibitex
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency
Yahoo/BusinessWire
Saturday, February 6, 2010 - 12:01pm
tags:
Talecris, orphan drugs, Alpha1-Proteinase Inhibitor, Alpha1-Antitrypsin Deficiency
FDA orders stronger label for Tysabri
bizjournals.com
Saturday, February 6, 2010 - 11:58am
tags:
Tysabri, Biogen Idec, PML, Elan
Optimer Pharma rises on fidaxomicin study data
Yahoo/AP
Saturday, February 6, 2010 - 11:53am
tags:
Optimer, C. difficile, fidaxomicin
Experts predict biotech doom with loss of gene patents
Fierce Biotech
Friday, February 5, 2010 - 10:50am
tags:
generics, Myriad, patents
Novo reps train for Victoza launch
Fierce Pharma
Friday, February 5, 2010 - 10:39am
tags:
Novo Nordisk, Victoza, sales reps, training
Wall Street Unleashes Fury at Pfizer's $1.5B Revenue Discrepancy
BNET Pharma
Friday, February 5, 2010 - 10:35am
tags:
Pfizer, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.